For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the emergence of Tafamidis and Attruby represents a significant breakthrough . These novel therapies https://pbm899352.livebloggs.com/48923495/major-attr-cm-development-the-drug-and-attruby-give-hope